Zymeworks Inc. (ZYME)
NASDAQ·Healthcare·Biotechnology
$26.46
-3.71%
Mkt Cap $1.98B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (21 analysts)
$40.50
Range $31.00 – $48.00
Implied Upside
+53.1%
Consensus $40.50 vs current $26.46
NASDAQ·Healthcare·Biotechnology
$26.46
-3.71%
Mkt Cap $1.98B
Buy
11
Hold
0
Sell
0
Price Target (21 analysts)
$40.50
Range $31.00 – $48.00
+53.1%
Consensus $40.50 vs current $26.46